Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Transforming Global Regulatory CMC Practices
"Transforming Global Regulatory CMC Practices in an Age of Revolutionary Innovation" features a panel of esteemed regulatory experts, including representatives from ANVISA, US FDA, EMA, PMDA, and WHO, who share their invaluable insights on global harmonization. View the Plenary Session
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (312)
- Cell & Gene Therapy Products (160)
- CE Pharm (150)
- Mass Spectrometry (146)
- Higher Order Structure (109)
- AT Europe (109)
- CMC Strategy Forum Europe (101)
- Bioassays (86)
- CMC Strategy Forum (78)
- CMC Strategy Forum Japan (72)
- CMC Strategy Forum North America January (52)
- CMC Strategy Forum North America July (50)
- CMC Strategy Forum Latin America (31)
- CMC Strategy Forum China (29)
- CGTP Summit (17)
- CMC Strategy Forum North America Fall (14)
- Biophysics Working Group (8)
- NorCal Regional Forum (6)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Consultants' Network (2)
- Midwest Regional Forum (2)
- Netherlands Area Biotech Discussion Group (1)
- CMC-Vaccines Working Group (1)
Filter By Tags
-
CE Pharm 2024 Summary Infographic
Summary Infographic: CE Pharm 2024
-
Role of CE for Therapeutic Nucleic Acids: Gene Therapy and Vaccines
Roundtable Session 1 Table 8 CE Pharm 2024
-
Peak Integration in CE
Roundtable Session 2 Table 8 CE Pharm 2024
-
Life Cycle Management of CE Technology
Roundtable Session 1 Table 9 CE Pharm 2024
-
Is High Throughput Always Better?
Roundtable Session 1 Table 7 CE Pharm 2024
-
iCIEF - Becoming the CE Expert in Your Organization – Best Practices Exchange [Session 2]
Roundtable Session 2 Table 3 CE Pharm 2024
-
iCIEF - Becoming the CE Expert in Your Organization – Best Practices Exchange
Roundtable Session 1 Table 3 CE Pharm 2024
-
ICHQ14 and What it Means to CE Method Development
Roundtable Session 2 Table 6 CE Pharm 2024
-
Characterization of single Peaks from CE separations [Session 2]
Roundtable Session 2 Table 5 CE Pharm 2024
-
Characterization of single Peaks from CE separations
Roundtable Session 1 Table 5 CE Pharm 2024
-
CGE - Becoming the CGE Expert in Your Organization – Best Practices Exchange [Session 2]
Roundtable Session 2 Table 2 CE Pharm 2024
-
CGE - Becoming the CGE Expert in Your Organization – Best Practices Exchange
Roundtable Session 1 Table 2 CE Pharm 2024
-
CE-MS in Regulatory Filings
Roundtable Session 2 Table 9 CE Pharm 2024
-
CE Methods and Method Robustness - DOE Designing
Roundtable Session 1 Table 4 CE Pharm 2024
-
CE/MS: Method Development, Application and Implementation in Biopharmaceutical Development
Roundtable Session 1 Table 6 CE Pharm 2024
-
CE Methods and Method Robustness - DOE Designing [Session 2]
Roundtable Session 2 Table 4 CE Pharm 2024
-
Building an Inclusive Knowledge Sharing Environment
Roundtable Session 2 Table 10 CE Pharm 2024
-
Analytical Platform Transfer: When and How Should it Be Done?
Roundtable Session 2 Table 7 CE Pharm 2024
-
Utilizing High-Throughput Capillary Electrophoresis for Bioprocess Development Support
Technical Seminar CE Pharm 2024Wei Brian, Sanofi, 2024
-
Partner Showcase, Revvity, Inc., 2024
Partner Showcase CE Pharm 2024Revvity, Inc., 2024